Selecta Biosciences, Inc.
Selecta Biosciences, Inc. (SELB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SELB · as of Jun 9, 2026
Key Statistics
Explore Selecta Biosciences, Inc. Data
selb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 90.9%
Competitors & Peers
selb competitorsSELB
ATYR
CYT
DBTX
FSTX
KNTEStock Performance
Full HistoryAbout Selecta Biosciences, Inc.
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to the research and development of innovative nanoparticle immunomodulatory medications aimed at treating and preventing …
what is selecta biosciences, inc. · selb stock overview · selecta biosciences, inc. company profile · who is selecta biosciences, inc. ceo · selb NASDAQ · selecta biosciences, inc. headquarters · selecta biosciences, inc. business segments
About Stock Overview & Key Data
Selecta Biosciences, Inc. (SELB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 22, 2016. As of the latest trading session, SELB stock price is $0.88, with a market capitalization of $135.2M. The stock has returned -32.73% over the past 12 months and -23.37% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Selecta Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Selecta Biosciences, Inc. reported revenue of $2.8M and net income of -$130.3M. For detailed data — including Selecta Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Selecta Biosciences, Inc. (SELB) stock price is $0.88. The stock is traded on NASDAQ under the ticker symbol SELB. The 52-week range is $0.79 – $1.99.